文献速递神经肿瘤

停用醋酸诺美孕酮后脑膜瘤自发消退:三例患者系列

Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients.
PubMed 文献 · Acta Neurochir (Wien) · 2019-02-19

本文报告三例长期服用孕激素激动剂醋酸诺美孕酮(NOMAC)的女性脑膜瘤患者,在实施激素暴露与脑膜瘤发生潜在相互作用的筛查方案后被识别。停用NOMAC后,所有脑膜瘤在第一个月内即出现体积缩小,其中一例在随访第一年观察到肿瘤体积缩小达70%。患者均未出现新症状。作者认为这是首例报道的脑膜瘤对停用NOMAC激素治疗有反应的病例。

要点

  • 三例服用NOMAC的脑膜瘤患者停药后第一个月内均出现肿瘤缩小。
  • 一例患者在随访第一年肿瘤体积缩小达70%。
  • 所有患者均未出现新症状。

核心结论

  • 作者报告了首例脑膜瘤对停用NOMAC激素治疗有反应的病例,与长期服用CPA相关病例类似,停用NOMAC后可观察到肿瘤缩小和临床症状改善。

研究设计与样本

  • 在实施筛查方案以检测激素暴露与脑膜瘤发生潜在相互作用后,识别出服用NOMAC并新诊断脑膜瘤的患者,停用NOMAC并进行密切临床和影像学随访,对影像进行回顾性体积分析;共识别三例患者。

主要发现

  • 停用NOMAC后,所有脑膜瘤在第一个月内均记录到肿瘤缩小。
  • 其中一例患者在随访第一年观察到肿瘤体积缩小达70%。
  • 没有患者出现新症状。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relationship between increased meningioma incidence and growth and long-term hormonal therapy with cyproterone acetate (CPA) in women has been recently established in literature. Following the raise in awareness from hormonal treatment, we describe a potential relationship between the progesterone agonist nomegestrol acetate (NOMAC) and meningioma growth. METHODS: After implementation of a screening protocol to detect potential interactions between hormonal exposure and occurrence of meningioma, we identified patients taking NOMAC and newly diagnosed with a meningioma. NOMAC was stopped and those patients were followed tightly both clinically and radiologically. Retrospective volumetric analysis of the tumors was performed on the imaging. RESULTS: Three patients were identified for the study. After cessation of the NOMAC, tumor shrinkage was documented for all meningiomas within the first month. Up to 70% of tumor volume reduction was observed during the first year of follow-up in one of them. None of the patients developed new symptoms. CONCLUSION: We report the first cases of meningiomas responsiveness to discontinuation of hormonal therapy with NOMAC. Similarly to cases associated with long-term CPA intake, tumor reduction, and improvement of clinical symptoms can be observed after cessation of NOMAC.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Passeri T, Champagne PO, Bernat AL, et al. Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien). 2019. PMID: 30783806. doi:10.1007/s00701-019-03848-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。